Медаль Джесси Стивенсон-Коваленко (англ.Jessie Stevenson Kovalenko Medal) — награда для учёных, внёсших значительный вклад в медицинские науки, присуждаемая Национальной академией наук США[1].
Выплата награды осуществляется из целевых средств (Kovalenko Gift) Фонда Джесси Стивенсон — Коваленко (Jessie Stevenson Kovalenko Fund), созданного в память своей супруги Джесси Стивенсон ушедшим на пенсию 60-летним бывшим профессором математики и астрономии Принстонского университета США Майклом С. (Михаилом Степановичем) Коваленко[укр.]. Предложение учредить награду было направлено им академии в 1948-49г[2].
For his outstanding contributions to medical science over a period of a half-century, both as an investigator and as a research executive and administrator.
For his outstanding contributions to medical science and for a life of exemplary devotion to medical education and inquiry into the origins of disease.
For his laboratory and epidemiological researches on virus diseases, including his major role in the program for the evaluation of the polio vaccine and for his imaginative design for long-term studies of the atomic bomb survivors in Japan.
For furthering the essential understanding of balance between hereditary and other biological factors, on the one hand, and psychosocial experimental ones, on the other, in the pathogenesis and manifestations of schizophrenia.
For his immeasurable contribution to the diagnosis and treatment of human disease during his career, which was devoted to the physiology and chemistry of respiration and the mechanical and chemical properties of the human lung.
For his studies of the Hageman trait, an experiment of nature that improved understanding of such bodily defenses as the formation and dissolution of blood clots, inflammation, and immunity.
For the discovery and characterization, with Avery and McLeod, that deoxyribonucleic acid is the chemical substance of heredity, and for his subsequent contributions to our understanding of the biology of streptococci and their role in disease.
For revolutionary accomplishments in human sphingolipid storage disorders, including the discovery of enzymatic defects, the development of genetic counseling procedures, and successful enzyme-replacement therapy.
For his discovery and purification of the hemotopoietic growth factors and for their introduction into clinical medicine for the control of blood cell formation and resistance to infection.
For his landmark discovery and identification of genes that control immune responsiveness, and for his subsequent elucidation of mechanisms of antigen recognition and induction of the immune response.
For his elucidation of the structure, function, and mechanism of regulation of heptahelical receptors, nature's detectors of signals from many hormones, neurotransmitters, and drugs.
For her discovery of recurring chromosome translocations that characterize specific hematological malignancies, a landmark event that caused a major shift in the paradigms relating to cancer biology in the 1970s and paved the way for development of specific treatment for two leukemias.
For his pioneering achievements in defining the molecular basis of blood disorders and the mechanisms governing the development of blood stem cells and individual blood lineages. His work has significantly advanced our understanding of human hematologic diseases and revealed new strategies to prevent and manage these disorders.
For her pioneering contributions to the fields of neurodegenerative proteinopathies, autism spectrum disorders, epigenetics, and developmental biology by coupling clinical observation and gene discovery with focused, in-depth mechanistic study.
For the discovery that antibody blockade of the T cell molecule CTLA-4 unleashes the body’s immune response against malignant tumors and develops immune checkpoint blockade as a successful cancer therapy.
For his pioneering work in elucidating the fundamental principles of the molecular basis of human cancer and the application of this knowledge to improve the clinical management of patients.
